- Home
- DTIL vs CBFV Comparison
DTIL vs CBFV Comparison
Compare DTIL & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | CBFV |
|---|---|---|
| Founded | 2006 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.3M | 180.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DTIL | CBFV |
|---|---|---|
| Price | $7.01 | $35.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $45.00 | $38.00 |
| AVG Volume (30 Days) | ★ 232.9K | 2.0K |
| Earning Date | 05-14-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $1,070,000,000.00 | $43,557,000.00 |
| Revenue This Year | N/A | $48.93 |
| Revenue Next Year | N/A | $7.97 |
| P/E Ratio | ★ N/A | $38.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.53 | $27.11 |
| 52 Week High | $8.82 | $37.75 |
Technical Indicators
Market Signals| Indicator | DTIL | CBFV |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 47.17 |
| Support Level | $4.56 | $34.39 |
| Resistance Level | $7.84 | $36.64 |
| Average True Range (ATR) | 0.53 | 0.28 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 59.50 | 7.58 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.